文献

J-GLOBAL ID：201702235918730179   整理番号：17A0087634

未治療の高-中間リスクと高リスクのびまん性大細胞型B細胞リンパ腫に対するupfront大量化学療法+リツキシマブとその後の自家末梢血幹細胞移植の効果:多施設前向き第二相試験(JSCT-NHL04)

Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04)

著者 (19件)： Murayama Tohru (Department of Hematology, Hyogo Cancer Center, Akashi, Hyogo, Japan) ,  Fukuda Takahiro (Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan) ,  Okumura Hirokazu (Hematology Department, Toyama Prefectural Central Hospital, Toyama, Japan) ,  Sunami Kazutaka (Division of Hematology, Department of Internal Medicine National Hospital Organization, Okayama Medical Center, Okayama, Japan) ,  Sawazaki Aiko (Department of Hematology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan) ,  Maeda Yoshinobu (Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan) ,  Tsurumi Hisashi (First Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan) ,  Uike Naokuni (Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan) ,  Hidaka Tomonori (Division of Gastroenterology and Hematology, University of Miyazaki Hospital, Miyazaki, Japan) ,  Takatsuka Yoshifusa (Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan) ,  Eto Tetsuya (Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan) ,  Tsuda Hiroyuki (Division of Hematology and Oncology, Kumamoto City Hospital, Kumamoto, Japan) ,  Fujisaki Tomoaki (Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan) ,  Miyamoto Toshihiro (Department of Hematology and Oncology, Kyusyu University Hospital, Fukuoka, Japan) ,  Tsuneyoshi Naoko (Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan) ,  Iyama Satoshi (Fourth Department of Internal Medicine, Sapporo Medical University Hospital, Sapporo, Japan) ,  Nagafuji Koji (Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan) ,  Harada Mine (Department of Internal Medicine, Karatsu Matsuura Ishikai Hospital, Karatsu, Japan) ,  Harada Mine (Japan Study Group for Cell Therapy and Transplantation (JSCT), Tochigi, Japan)
資料名： International Journal of Hematology  (International Journal of Hematology)
巻： 103  号： 6  ページ： 676-685  発行年： 2016年06月 
JST資料番号： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 新しく診断された高-中間(HI)リスクと高(H)リスクのびま...

シソーラス用語： *B細胞リンパ腫 ,...
準シソーラス用語： *びまん性大細胞型B細胞リンパ腫 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0087634&from=J-GLOBAL&jstjournalNo=F0888A") }}

著者キーワード (5件)： Diffuse large B-cell lymphoma ,  Autologous peripheral blood stem cell transplantation ,  High-dose chemotherapy ,  CHOP14 ,  Rituximab

分類 (2件)： 腫ようの治療一般  (GE03031L) ,  血液の腫よう  (GK04000M)

物質索引 (4件)： ドキソルビシン塩酸塩 ,  シクロホスファミド ,  ビンクリスチン硫酸塩 ,  プレドニゾロン

引用文献 (36件)：

• The Non-Hodgkin’s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood. 1997;89:3909-18.
• Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235-42.
• Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de L’Adulte. J Clin Oncol. 2005;23:4117-26.
• Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good prognosis diffuse large B-cell lymphoma: a randomized controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;7:379-91.
• Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006;24:3121-7.

タイトルに関連する用語 (9件)： 治療 ,  高 ,  リスク ,  びまん性大細胞型B細胞リンパ腫 ,  大量化学療法 ,  リツキシマブ ,  自家末梢血幹細胞移植 ,  施設 ,  第二相試験